CRASH-3 试验中治疗时间估计的准确性及其对结果的影响
基于 CRASH-3 试验(12,737 例 TBI 患者)中 8,107 例 GCS 9–15 分患者,将临床记录的治疗时间与 1,368 例的监测数据核对,并用多种方法校正时间误差。结果显示临床时间常被取整,平均低估 9 分钟,但校正后治疗效应估计变化很小。
要点
- 临床记录的治疗时间常被取整,平均低估 9 分钟(95%CI -85, 66)。
- 监测时间估计的 1 小时治疗效应 OR=0.61,临床记录为 OR=0.63。
- 校正已知时间误差对试验结果影响很小。
核心结论
- 准确估计从受伤到治疗的时间具有挑战性,尤其在低资源环境中。
- 校正已知的治疗时间误差对试验结果影响很小。
研究设计与样本
- CRASH-3 是一项随机试验,纳入 12,737 例 TBI 患者,评估氨甲环酸对死亡和血管闭塞事件的影响。
- 本分析纳入 8,107 例 GCS 9–15 分患者,并对 1,368/12,737(11%)例患者的临床记录治疗时间与救护车及医院记录进行核对。
主要发现
- 66% 的病例临床医生将时间取整到最近半小时或整小时。
- 监测时间与临床时间在 63% 的患者中完全相同,时间平均被低估 9 分钟(95%CI -85, 66)。
- 中低收入国家临床记录与监测时间的变异性高于高收入国家。
- 1 小时治疗效应估计:监测时间 OR=0.61(95%CI 0.47, 0.81),临床记录时间 OR=0.63(95%CI 0.48, 0.83)。
- 三种校正方法得到相似的治疗时间交互作用;贝叶斯法 1 小时治疗效应 OR=0.58(95%CI 0.43, 0.78)。
关键数值与推荐
- 使用监测时间使治疗时间交互项从 1.15(95%CI 1.03, 1.27)变为 1.16(95%CI 1.05, 1.28)。
临床怎么用
- 临床记录的治疗时间虽存在取整和低估,但校正后治疗效应估计稳定,支持主要试验结论的稳健性。
局限性
- 仅对 1,368/12,737(11%)例患者进行了时间监测,且优先选择死亡患者(监测了 36% 的颅脑损伤死亡)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Early treatment with tranexamic acid may reduce deaths after traumatic brain injury (TBI). In mild and moderate TBI, there is a time to treatment interaction, with early treatment being most beneficial. Time to treatment was recorded by clinicians and is subject to error. Using monitoring data from the CRASH-3 trial, we examine the impact of errors in time to treatment on estimated treatment effects. METHODS: The CRASH-3 trial was a randomised trial of the effect of tranexamic acid on death and vascular occlusive events in 12,737 TBI patients. This analysis includes the 8107 patients with a Glasgow coma scale score of 9 to 15 since previous analyses showed that these patients benefit most from early treatment. Clinician-recorded time to treatment was checked against ambulance and hospital records for 1368/12,737 (11%) patients. Patients who died were preferentially selected for monitoring and we monitored 36% of head injury deaths. We describe measurement errors using Bland-Altman graphs. We model the effect of tranexamic acid on head injury death using logistic regression with a time-treatment interaction term. We use regression calibration, multiple imputation and Bayesian analysis to estimate the impact of time to treatment errors. RESULTS: Clinicians rounded times to the nearest half or full hour in 66% of cases. Monitored times were also rounded and were identical to clinician times in 63% of patients. Times were underestimated by an average of 9 min (95% CI - 85, 66). There was more variability between clinician-recorded and monitored times in low- and middle-income countries than in high-income countries. The treatment effect estimate at 1 h was greater for monitored times OR = 0.61 (95% CI 0.47, 0.81) than for clinician-recorded times OR = 0.63 (95% CI 0.48, 0.83). All three adjustment methods gave similar time to treatment interactions. For Bayesian methods, the treatment effect at 1 h was OR = 0.58 (95% CI 0.43, 0.78). Using monitored times increased the time-treatment interaction term from 1.15 (95% CI 1.03, 1.27) to 1.16 (95% CI 1.05, 1.28). CONCLUSIONS: Accurate estimation of time from injury to treatment is challenging, particularly in low resource settings. Adjustment for known errors in time to treatment had minimal impact on the trial results. TRIAL REGISTRATION: ClinicalTrials.gov NCT01402882 . Registered on 25 July 2011.
引用
- Mansukhani R, Frimley L, Shakur-Still H, et al. Accuracy of time to treatment estimates in the CRASH-3 clinical trial: impact on the trial results. Trials. 2020. PMID: 32711551. doi:10.1186/s13063-020-04623-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。